The Turkish version of neurological disorders depression inventory epilepsy for youth (NDDI-E-Y); validity and reliability study


Aydın S., Öz Tunçer G., Bayir G. K., Aksoy A.

Brain and Development, cilt.48, sa.3, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 3
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.braindev.2026.104532
  • Dergi Adı: Brain and Development
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Psycinfo, Academic Search Ultimate (EBSCO)
  • Anahtar Kelimeler: Depression, NDDI-E-Y, Screening, Youth with epilepsy
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Introduction: Although depression is one of the most common comorbidities in patients with epilepsy, it is often undiagnosed. The aim of this study was to verify the validity and reliability of the Turkish version of the Neurological Disorders Depression Inventory-Epilepsy for Youth (NDDI-E-Y), which is used to determine depressive symptoms in children with epilepsy. Methods: Children with epilepsy aged between 12 and 17 years were included. The Turkish versions of the Child Depression Inventory (CDI) and NDDI-E-Y were applied to the participants. Results: All of the 116 participants were able to complete the scale without any difficulty in understanding the Turkish version of the NDDI-E-Y. Cronbach's α coefficient was 0.88. Receiver operator characteristics (ROC) analysis was performed and the area under the curve (AUC) for NDDI-E-Y was 0.983 (95% CI 0.940–0.998), the optimum cut-off score was >32 with 90.5% sensitivity and 96.8% specificity. NDDI-E-Y Turkish version scores showed a significant positive correlation with CDI (p < 0.05). Conclusion: The Turkish version of the NDDI-E-Y can be used as a valid and reliable measurement tool for children with epilepsy. We believe that the routine use of this short, self-administered scale in intensive clinical settings will contribute to the diagnosis and treatment of depression in children with epilepsy.